Ankle-brachial index: A useful tool for stratifying cardiovascular risk;Índice tobillo-brazo: Una herramienta útil en la estratificación del riesgo cardiovascular

Revista Espanola de Cardiologia

Volumn 59, Issue 7, 2006, Pages 647-649

  Lahoz, Carlos ^a   Mostaza, José M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANKLE BRACHIAL INDEX; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EDITORIAL; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; METABOLIC SYNDROME X; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRESSURE GRADIENT; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE; ANKLE; ARM; BLOOD PRESSURE MEASUREMENT; METHODOLOGY; NOTE;

ANKLE; ARM; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; HUMANS; RISK ASSESSMENT;

EID: 33748484694     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091364     Document Type: Editorial

References (19)

1. Rodriguez-Artalejo F, Banegas B Jr. De la ecuación de Framingham a la prevención cardiovascular. Med Clin (Barc). 2003;121: 334-6.
2. Bisoendial RJ, Hovingh GK, De Groot E, Kastelein JJ, Lansberg PJ, Stroes ES. Measurement of subclinical atherosclerosis: beyond risk factor assessment. Curr Opin Lipidol. 2002;13:595-603.
3. Mostaza JM, Vicente I, Cairols M, Castillo J, Gonzalez-Juanatey JR, Pomar JL, et al. Índice tobillo brazo y riesgo cardiovascular. Med Clin (Barc). 2003;121:68-73.
4. Baker JD, Dix DE. Variability of Doppler ankle pressures with arterial occlusive disease: an evaluation of ankle index and brachial-ankle pressure gradient. Surgery. 1981;89:134-7.
5. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol. 1988; 17:248-54.
6. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286: 1317-24.
7. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
8. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538-45.
9. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke. 2001;32:1721-4.
10. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/ AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-e54.
11. Manzano L, García-Díaz J, Gómez-Cerezo J, Mateos J, Del Valle F, Medina-Asensio J, et al. Valor de la determinación del índice tobillo-brazo en pacientes de riesgo vascular sin enfermedad aterotrombótica conocida: estudio VITAMIN. Rev Esp Cardiol. 2006;59:662-70.
12. Vicente I, Lahoz C, Taboada M, Garcia A, San Martin MA, Terol I, et al. Prevalencia de un índice tobillo-brazo patológico según el riesgo cardiovascular calculado mediante la función de Framingham. Med Clin (Barc). 2005;124:641-4.
13. Lahoz C, Vicente I, Taboada M, Laguna F, Garcia-Iglesias F, Mostaza JM. Índice tobillo-brazo y riesgo cardiovascular estimado mediante la función de SCORE en sujetos no diabéticos en prevención primaria. Clin Invest Arterioscl. 2006;18:35-9.
14. Vicente I, Lahoz C, Taboada M, Laguna F, García-Iglesias F, Mostaza JM. Índice tobillo-brazo en pacientes con diabetes mellitus: prevalencia y factores de riesgo. Rev Clin Esp. 2006;206: 225-9.
15. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333-41.
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
17. Lahoz C, Vicente I, Laguna F, Garcia-Iglesias MF, Taboada M, Mostaza JM. Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care. 2006;29:148-50.
18. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006;113:388-93.
19. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733-9.